GLUE icon

Monte Rosa Therapeutics
GLUE

Overview Fund Activity

68 hedge funds and large institutions have $281M invested in Monte Rosa Therapeutics in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
-3
Holders Change %
-4.23%
% of All Funds
0.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
20
Reduced
22
Closed
13
Calls
$685K
Puts
$96K
Net Calls
+$589K
Net Calls Change
-$1.08M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$35.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
$851K
3
Millennium Management
Millennium Management
New York
$1.06M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$512K
5
Geode Capital Management
Geode Capital Management
Massachusetts
$5.19M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$37.7M
2
CS
Candriam SCA
Luxembourg
$0
3
Morgan Stanley
Morgan Stanley
New York
$393K
4
CM
Caption Management
Oklahoma
$0
5
BlackRock
BlackRock
New York
$16.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
SG Americas Securities
76
SG Americas Securities
New York
– -$69K -12,257 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
– -$59.9K -10,602 Closed
Invesco
78
Invesco
Georgia
– -$59.4K -10,518 Closed
Simplex Trading
79
Simplex Trading
Illinois
– -$56K -10,043 Closed
PMEF
80
Point72 Middle East FZE
United Arab Emirates
– -$52.5K -9,290 Closed
1 2 3
4